Picture of Vaxart logo

VXRT — Vaxart News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Vaxart Inc expected to post a loss of 23 cents a share - Earnings Preview

* Vaxart Inc  VXRT.OQ   VXRT.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 22
(estimated). 
    * The South San Francisco California-based  company is
expected to
report  a 812.2% increase in revenue to $675 thousand from $74
thousand a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vaxart Inc is for a
loss
of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxart Inc
is
$6.5​, above​ its last closing price of $0.99. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.25       -0.24      -0.23     Beat    5.2
 Jun. 30 2022  -0.22       -0.21      -0.23     Missed  -9.5
 Mar. 31 2022  -0.16       -0.16      -0.20     Missed  -23.1​
 Dec. 31 2021  -0.17       -0.17      -0.17     Met     0
 ​​Sep.        -0.15       -0.15      -0.14     Beat    4.5
 30 2021                                                
 Jun. 30 2021  -0.14       -0.14      -0.13     Beat    8.8​
 Mar. 31 2021  -0.10       -0.10      -0.14     Missed  -40
 Dec. 31 2020  -0.05       -0.08      -0.13     Missed  -62.5
 This summary was machine generated February 21 at 03:02 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Vaxart

See all news